“As prescription opioid use disorder reaches epidemic proportions in the United States, finding successful treatments for the condition has become hugely important.
Now, research shows that treating opioid-dependent patients with buprenorphine, a partial μ-opioid agonist and κ-opioid antagonist, appears to reduce the need for opioids.
Presented here at the American Psychiatric Association (APA) 2016 Annual Meeting, results of an extension trial showed that fewer than 10% of patents originally dependent on prescription opioids who were initially treated with buprenorphine were opioid dependent after 42 months.
However, some of these patients started taking heroin.”
Read more at: http://www.medscape.com/viewarticle/863801 (Free registration required)
Source: Medscape.com – May 25, 2016